HPV, tetanus vaccines causes deadly new autoimmune
disease known as antiphospholipid syndrome
Tuesday, February 12, 2013 by: Ethan A. Huff, staff writer
(NaturalNews) One of the latest technologies being employed in the production of
new vaccines involves the use of outer membrane vesicles (OMVs), a type of
pathogenic bacteria that mimics the phospholipids naturally found in the human
body, as customizable vaccine adjuvants. But vaccines that utilize this untested
technology, which include vaccines for tetanus, human papillomavirus (HPV), and
influenza, are now being linked to causing a potentially deadly autoimmune
disease known as antiphospholipid syndrome (APS).
Several recent studies published in prominent medical journals have investigated
the connection between APS, which belongs to a wider class of vaccine-induced
health conditions known as autoimmune/inflammatory syndrome induced by adjuvants
(ASIA), and vaccines, and found that OMVs are directly linked to triggering APS.
Like the common vaccine adjuvant squalene, vaccine phospholipid materials, when
injected into bodily tissue, can trigger an immune response that ends up causing
the body to attack its own natural phospholipids.
As far as the tetanus vaccine is concerned, injections containing OMVs and
recombinant (genetically-modified) DNA are being shown to cause blindness,
cardiovascular disease, headaches and migraines, miscarriages, skin disorders,
ulcers, necrosis, and neurological disorders. And as an increasing amount of
vaccines are quietly converted to OMV-based adjuvant blends, the prevalence of
APS is also expected to continue rising, as it already has been for quite some
"OMVs are even more precisely analogous to human tissue (than squalene), because
they are not only lipids, they are phospholipids -- which are precisely what the
body attacks in APS," explains Heidi Stevenson from Gaia Health about the
growing prevalence of vaccine-induced APS. "Therefore, we can anticipate that
there will be ever-more cases of APS as we see the approval of ever-more OMV-based
vaccines, which are in the pipeline now."
Cervarix, the HPV vaccine
rival to Merck & Co.'s Gardasil, contains OMVs, as do some flu vaccines -- and
many more common vaccines are being reformulated with OMVs at this very moment.
What this means is that we can expect an increasing number of vaccinated
individuals to develop autoimmune symptoms as we move forward into the future.
And such symptoms are likely to be systemic, as APS can target virtually all
areas of the body.
"People with APS are suffering from phospholipid antibodies that are erroneously
destroying parts of the eye, cardiovascular system, brain, nerves, skin,
reproductive system -- in short, any part of the body," adds Stevenson about the
horrific nature of this relatively new condition. "This self-destruction is
induced by vaccine technologies."
Be sure to read Stevenson's full report on vaccine-induced APS here:
Sources for this article include: